Xigduo XR 5/1000mg (Dapagliflizin/Metformin - Extended Release )
Active ingredient | Dapagliflizin/Metformin - Extended Release |
---|---|
Dispensing Country | India |
Xigduo Medicine Description
Drug Class:
- Combination Antidiabetic Agent
- Xigduo belongs to a class of drugs called Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors and Biguanides.
Categories:
- Antidiabetic Medication
- Type 2 Diabetes Management
Active Ingredient Name:
- Dapagliflozin (SGLT2 Inhibitor)
- Metformin (Biguanide)
Popular and Other Names:
- Xigduo XR
- Dapagliflozin/Metformin Combination
- SGLT2 Inhibitor and Metformin Combination
- Extended-Release Dapagliflozin/Metformin Tablets
Mode of Action:
Xigduo combines the effects of Dapagliflozin and Metformin to manage blood sugar levels in people with Type 2 diabetes.
-
Dapagliflozin: Works by blocking the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, reducing glucose reabsorption, and promoting the excretion of glucose through urine. This lowers blood sugar levels.
-
Metformin: Decreases glucose production in the liver and improves the body’s sensitivity to insulin, helping the body use glucose more effectively.
The combination of these two mechanisms helps provide better control of blood glucose levels in patients with Type 2 diabetes.
How to Use Xigduo:
- Form: Oral tablet, extended-release.
- Administration: Take Xigduo XR once daily in the morning with food to minimize gastrointestinal side effects.
- Instructions: Swallow the tablet whole; do not crush, chew, or break it. Taking it with meals helps to reduce the risk of stomach upset.
Recommended Dosage:
-
Starting Dose:
For patients new to SGLT2 inhibitors, the typical starting dose is 5 mg of Dapagliflozin/500 mg of Metformin extended-release once daily. -
Adjustments:
The dose may be adjusted depending on blood glucose levels, kidney function, and tolerance to Metformin. Your doctor may gradually increase the dose to a maximum of 10 mg of Dapagliflozin/2000 mg of Metformin once daily.
Directions:
-
Consistency is Key:
Take Xigduo XR at the same time every day to maintain consistent blood sugar levels. -
Do Not Skip Meals:
Eating regularly is important to avoid low blood sugar, especially when using antidiabetic medications. -
Monitor Blood Sugar Levels:
Regularly check your blood sugar levels to ensure that Xigduo XR is working effectively. -
Proper Hydration:
Drink plenty of fluids, as Xigduo increases urination and the risk of dehydration.
Cautions:
-
Kidney Function:
Patients with severe kidney impairment should not use Xigduo, as it can increase the risk of lactic acidosis from Metformin and worsen kidney function. -
Dehydration Risk:
Since Dapagliflozin increases urination, there is a risk of dehydration. Ensure adequate fluid intake throughout the day. -
Hypoglycemia:
While Xigduo itself does not cause low blood sugar, combining it with other antidiabetic drugs (e.g., insulin) may increase the risk of hypoglycemia. Monitor blood sugar levels closely. -
Lactic Acidosis:
Metformin can, in rare cases, cause a serious condition called lactic acidosis. Seek medical attention if you experience symptoms like muscle pain, difficulty breathing, or severe weakness.
Managing Side Effects:
-
Common Side Effects:
- Increased urination
- Thirst
- Nausea
- Diarrhea or stomach upset
Management:
Drink plenty of water and stay hydrated. Taking Xigduo with food can help reduce gastrointestinal side effects like nausea and diarrhea. -
Serious Side Effects:
- Ketoacidosis
- Severe dehydration
- Lactic acidosis
Action:
Seek immediate medical help if you experience symptoms of severe side effects like extreme thirst, confusion, or muscle pain. Discontinue use and inform your healthcare provider if serious symptoms arise.
Guidelines:
-
Lifestyle Changes:
Xigduo works best when combined with a healthy diet and regular exercise. Consult your healthcare provider for a personalized diet and exercise plan to support blood sugar control. -
Kidney and Liver Monitoring:
Regular kidney and liver function tests are necessary to ensure Xigduo is safe for long-term use. -
Pregnancy and Breastfeeding:
Xigduo is not recommended for use during pregnancy or breastfeeding. Consult your doctor for alternative options if you are pregnant or planning to conceive. -
Avoid Alcohol:
Alcohol may increase the risk of lactic acidosis with Metformin. Limit alcohol consumption while taking Xigduo.
Frequently Asked Questions (FAQs):
-
What is Xigduo used for?
Xigduo is used to manage Type 2 diabetes by lowering blood sugar levels and reducing the risk of cardiovascular events in diabetic patients. -
Can Xigduo cause weight loss?
Yes, one of the effects of Xigduo, especially due to Dapagliflozin, is mild weight loss, as it promotes glucose excretion through urine. -
Can I take Xigduo with other diabetes medications?
Yes, Xigduo can be taken alongside other diabetes medications. However, this increases the risk of hypoglycemia, so dosage adjustments may be necessary. -
What should I do if I miss a dose of Xigduo?
If you miss a dose, take it as soon as you remember. If it’s near the time of your next dose, skip the missed dose. Do not double the dose to catch up. -
Are there any foods to avoid while taking Xigduo?
There are no specific food restrictions, but it is important to follow a balanced diet to help manage blood sugar levels effectively. -
Does Xigduo cause urinary tract infections?
Yes, Dapagliflozin in Xigduo can increase the risk of urinary tract infections. If you experience symptoms like painful urination, consult your doctor.
Quick Links:
-
Xigduo and Type 2 Diabetes Management
Learn how Xigduo helps manage blood sugar levels in patients with Type 2 diabetes. -
Xigduo Dosage Guidelines
Understand the correct dosage for Xigduo and what adjustments may be required based on individual health conditions. -
Managing Side Effects of Xigduo
Tips on managing common side effects like dehydration, nausea, and gastrointestinal issues. -
Cautions for Taking Xigduo
Important information on the precautions you need to take while using Xigduo, especially regarding kidney function and the risk of lactic acidosis.